Decibel Receives Final TSX Venture Exchange Acceptance For AgMedica Acquisition And Debenture Conversion
Decibel Receives Final TSX Venture Exchange Acceptance For AgMedica Acquisition And Debenture Conversion
Decibel Cannabis Company Inc. (TSXV:DB) (OTCQB:DBCCF) announced Tuesday that it has received final acceptance from the TSX Venture Exchange for its previously announced acquisition of a Canadian licensed producer of cannabis, AgMedica Bioscience Inc.
Decibel大麻股公司（TSXV:DB）（OTCQB:DBCCF）于周二宣布已获得交易所对其此前宣布的收购一家加拿大持牌大麻生产商AgMedica Bioscience Inc.的最终接受。
The acquisition, arranged through an agreement with Callisto Capital Corp. on October 28, 2024, was made in exchange for a $6.3 million unsecured convertible debenture. As a result of receiving the acceptance, Decibel has completed the conversion of the convertible debenture, pursuant to which it has issued 114.55 million common shares to Callisto.
该收购是通过与Callisto Capital corp.于2024年10月28日达成的协议进行的，交换条件为630万无担保可转换债券。由于收到接受，Decibel已完成可转换债券的转换，依据此，它向Callisto发行了11455万普通分享。
The conversion of the convertible debenture was conditional upon receipt of final TSXV acceptance for the acquisition of AgMedica pursuant to Exchange Policy 5.3. This policy would have required approval from disinterested shareholders if Callisto became a major controller of the company. However, because the company has finished its recent private funding, Callisto will not control the company after the bond is converted. Therefore, approval from disinterested shareholders is not needed for the conversion.
可转换债券的转换以获得交易所政策5.3下对AgMedica收购的最终TSXV接受为条件。该政策要求如果Callisto成为公司的主要人形机器人-电机控制器，则需要不相关股东的批准。然而，由于公司完成了最近的定向增发，Callisto在债券转换后将不会控制公司。因此，转换不需要不相关股东的批准。
Read Also: Cannabis Giant High Tide Taps Into $113 Billion Global E-Commerce Market With New Product Categories
另见：大麻巨头High Tide新产品类别进军1130亿全球电子商务市场
Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter here. If you're serious about the business, you can't afford to miss out.
订阅本新闻快讯，每天免费获取Benzinga独家分析和大麻股行业及市场的最新资讯。如果您对业务认真，不容错过。在这里订阅我们的新闻简报。
On Nov. 25, the Calgary, Alberta-based cannabis company confirmed completion of the second and final closing of non-brokered private placement of its common shares at $0.06 per share. At the second closing of the offering, it issued 19.65 million shares for gross proceeds of roughly $1.18 million.
11月25日，总部位于卡尔加里，阿尔伯塔省的大麻公司确认完成其以每分享$0.06的普通分享的非中介定向增发的第二次和最终闭幕。在第二次闭幕中，它发行了1965万分享，粗略收益约为118万。
Previously, Decibel projected that AgMedica could contribute $30 million of net revenue and $4 million of EBITDA in 2025, totaling an anticipated $130 million of net revenue and $25 million of adjusted EBITDA in 2025 on a pro-forma basis.
之前，Decibel预计AgMedica在2025年可贡献3000万的营业收入和400万的EBITDA，预测2025年总营业收入为13000万，调整后EBITDA为2500万，基于形式预测。
The transaction is expected to materially expand Decibel's international footprint with EU GMP certification that enables export of flower and a variety of extract products, with proven sales to seven different countries including Australia, Denmark, Germany, Israel, Norway, Spain and the United Kingdom.
该交易预计将显著扩大Decibel的国际足迹，符合欧盟GMP认证，可导出花和多种提取产品，已证明向包括澳洲、丹麦、德国、以色列、挪威、西班牙和英国在内的七个不同国家销售。
Price Action
股价变动
Decibel shares closed Monday's market session 6.62% higher at $0.0499 per share.
Decibel的股价在周一的市场交易中上涨了6.62%，每股价格为$0.0499。
- Canadian Cannabis Co. Decibel Reports 12% YoY Drop In Q3 Revenue But Increases Gross Margin To 53%
- Health Canada Cuts $14.6M From Cannabis Program Amid Federal Austerity
- 加拿大大麻股公司Decibel报告第三季度营业收入同比下降12%，但毛利率提升至53%。
- 加拿大卫生部在联邦紧缩政策中削减了1460万加元的大麻股项目。
Photo: Courtesy of pashabo via Shutterstock
图片来源：pashabo via shutterstock
